GSK3B and breast cancer: Exposure of DATS in breast cancer cells has enhanced c-Myc and GSK-3β expression levels while downregulated the expression levels of phospho-glycogen synthase kinase-3β (p-GSK-3β), and ß-catenin (Johnston, 2010).